Richard Payerchin

Technology was used for rapid creation of shots against COVID-19.

Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, considers possible effects of the COVID-19 pandemic on physician discipline.

Senators formally introduce act that has been in discussion since summer.

Top-down solutions are needed to expand the workforce and reduce burnout, not just free up a few minutes here and there.

A century of breakthrough, discovery and invention — and the pioneers who made medical history.

'I can see my bones!'

'Church bells rang out'

'From weird and wonderful places'

'The rational treatment of disease.'

"Plaster and sticks and casts and traction."

Advances in infection control, surgery, antibiotics and trauma that are used to treat patients today were essentially forged on the field of battle over the last 100 years.

“He ultimately saw it as a way to improve people’s lives.”

Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, discusses findings.

Offices successful in diabetes treatment have common characteristics of high performance.

Federal investigators allege kickbacks, money laundering in Texas.

Survey examines patient feelings about doctors and emerging technology.

Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, discusses state-level information about physician disciplinary actions.

Informational webinar scheduled for this week for physicians, other clinicians and practice managers.

Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, explains limited public access.

Patients with greater health risks had more screenings and more savings, without extending full health insurance in New York City.

Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, explains the National Practitioner Data Bank.

Legislation has bipartisan support, but critic says it’s throwing money at a problem with no guarantee it will help.

NAACOs fall conference features speakers on risk and success.

Democrats say their objections are the bidding of big pharma.

Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, describes serious disciplinary actions.

Robert E. Oshel, PhD, an adviser to the Public Citizen Health Research Group, explains history of the report.

Price transparency has gotten better, but still needs work to make costs clear to patients, a new study finds.

Free system moves company into patient engagement, CEO says.

Cleveland Clinic survey examines effects of lifestyle and habits on overall health.

Machine learning, robotics, and nanotechnology will have a growing place in medicine.